Ru-Lei Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ru-Lei Zhang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- David Wei Zhang
State Key Lab of ASIC & Systems, Fudan University, Shanghai 201203, China
4 shared publications - Zhan-Ting Li
State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 200032, China
4 shared publications - Hui Wang
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
3 shared publications - Shi-Xian Gan
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
3 shared publications - Congying Guo
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
2 shared publications - Gang Zhao
School of Materials Science and Engineering
2 shared publications
Latest Publications
- 2 October 2026
- Published by Georg Thieme Verlag KG in Synlett
Donor–Acceptor Interaction-Driven Inclusion of Tetraimidazolium Cyclophanes to Carbanions That Induces pK a Shifting of Conjugated Carbonic Acids in Water
Two tetraimidazolium-incorporated macrocycles have been prepared and used to include carbanionic conjugate bases of phenylmalononitriles through donor–acceptor interaction. X-ray diffraction analysis revealed that the two substrates form stable 1:1 complexes, with the carbanion being inserted in the cavity of the macrocycle. Fluorescence titration assays in water were used to determine the binding constants of totally 18 complexes, which range from 1.83 × 105 to 8.96 × 106 M −1. The high binding stability induced the formation of a charge-transfer absorption band around 400 nm and the pK a of the carbon acids in water to shift by −0.79 to −2.52 units, which correspond to 6.2- to 332-fold acidity enhancement. The result shows that conjugate carbanions are new, useful electron-rich donors to form donor–acceptor complexes with electron-deficient substrates for the research of supramolecular chemistry.
- 2 October 2026
- Published by Georg Thieme Verlag KG in Synlett
Donor–Acceptor Interaction-Driven Inclusion of Tetraimidazolium Cyclophanes to Carbanions That Induces pK a Shifting of Conjugated Carbonic Acids in Water
Two tetraimidazolium-incorporated macrocycles have been prepared and used to include carbanionic conjugate bases of phenylmalononitriles through donor–acceptor interaction. X-ray diffraction analysis revealed that the two substrates form stable 1:1 complexes, with the carbanion being inserted in the cavity of the macrocycle. Fluorescence titration assays in water were used to determine the binding constants of totally 18 complexes, which range from 1.83 × 105 to 8.96 × 106 M −1. The high binding stability induced the formation of a charge-transfer absorption band around 400 nm and the pK a of the carbon acids in water to shift by −0.79 to −2.52 units, which correspond to 6.2- to 332-fold acidity enhancement. The result shows that conjugate carbanions are new, useful electron-rich donors to form donor–acceptor complexes with electron-deficient substrates for the research of supramolecular chemistry.
- 17 July 2026
- Published by Elsevier in Chinese Chemical Letters
- Vol. 38 (2)
Donor-acceptor interaction-driven inclusion of carbanions by molecular cage induces large pKa shifts of conjugate carbon acids in water
- 17 July 2026
- Published by Elsevier in Chinese Chemical Letters
- Vol. 38 (2)
Donor-acceptor interaction-driven inclusion of carbanions by molecular cage induces large pKa shifts of conjugate carbon acids in water
- 29 May 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (11) , 13966-13979
Fluorinated Ultralong-Acting Neuromuscular Blocking Agent with Improved Activity Profile and Biosafety for the Development of Blockade and Reversal Partner Drugs
Halogenation has been used as a useful strategy to optimize an imidazolium-based macrocyclic ultralong-acting neuromuscular blocking agent for improved bioactivity and biocompatibility. A structure–activity relationship study for 18 compounds reveals that monofluorinated macrocycle IMC-X5 displays blockade profiles generally superior to those of lead compound IMC-0. In vivo tests with a rat model show that, compared with those of IMC-0, the onset, profound blockade, and moderate blockade-to-spontaneous respiration times of IMC-X5 at the same dose of 0.2 mg/kg shortens by 47%, extends by 34%, and shortens by 89%, respectively, while the onset activity surpasses that of cisatracurium, one of the main neuromuscular blocking agents, of a clinically associated dose. Moreover, the profound blockade of IMC-X5 can be rapidly reversed by a biocompatible acyclic cucurbit[n]uril (ACB) antagonist at any stage of blockade. IMC-X5 also exhibits a biosafety superior to that of IMC-0. The two agents thus form a promising partnership featuring ultralong-acting blockade and on-demand reversal.
- 29 May 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (11) , 13966-13979
Fluorinated Ultralong-Acting Neuromuscular Blocking Agent with Improved Activity Profile and Biosafety for the Development of Blockade and Reversal Partner Drugs
Halogenation has been used as a useful strategy to optimize an imidazolium-based macrocyclic ultralong-acting neuromuscular blocking agent for improved bioactivity and biocompatibility. A structure–activity relationship study for 18 compounds reveals that monofluorinated macrocycle IMC-X5 displays blockade profiles generally superior to those of lead compound IMC-0. In vivo tests with a rat model show that, compared with those of IMC-0, the onset, profound blockade, and moderate blockade-to-spontaneous respiration times of IMC-X5 at the same dose of 0.2 mg/kg shortens by 47%, extends by 34%, and shortens by 89%, respectively, while the onset activity surpasses that of cisatracurium, one of the main neuromuscular blocking agents, of a clinically associated dose. Moreover, the profound blockade of IMC-X5 can be rapidly reversed by a biocompatible acyclic cucurbit[n]uril (ACB) antagonist at any stage of blockade. IMC-X5 also exhibits a biosafety superior to that of IMC-0. The two agents thus form a promising partnership featuring ultralong-acting blockade and on-demand reversal.
- 18 February 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (8) , 8437-8446
Artificial Spherical Chromatophore Mimicking LH2 and LH1–RC for Highly Efficient Photocatalytic Hydrogen Production with Turnover Number >667,000
The supramolecular architecture of light-harvesting complex 2 (LH2) and light-harvesting complex 1-reaction center (LH1-RC) complexes underpins the near-unity quantum efficiency of photosynthesis in purple bacteria. Constructing artificial photosynthetic systems that structurally and functionally mimic these natural assemblies remains a critical challenge. Here, we report a spherical chromatophore nanomicelle system that mimics both LH2 and LH1-RC in water. This system is constructed through hierarchical coassembly of an amphiphilic porphyrin-based bacteriochlorophyll analogue and a cationic molecular nickel catalyst. Cryogenic electron microscopy directly resolves high-resolution ring-like structures on the nanomicelle surface, providing the first visual confirmation of the biomimetic architecture. The system achieves photocatalytic hydrogen evolution with a turnover number exceeding 667,000 over 72 h and a turnover frequency of above 9000 h-1 with an absolute hydrogen yield of 1.34 μmol─40 times greater than the nonassembled free molecular system─along with an initial external quantum efficiency of 6.8% at 435 nm. This outstanding performance originates from the well-defined spatial organization of the photosensitizers and catalysts, which facilitates efficient light harvesting and directional energy/electron transfer. Our work establishes a promising strategy for constructing high-performance artificial photosynthetic systems through rational biomimetic design.
- 18 February 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (8) , 8437-8446
Artificial Spherical Chromatophore Mimicking LH2 and LH1–RC for Highly Efficient Photocatalytic Hydrogen Production with Turnover Number >667,000
The supramolecular architecture of light-harvesting complex 2 (LH2) and light-harvesting complex 1-reaction center (LH1-RC) complexes underpins the near-unity quantum efficiency of photosynthesis in purple bacteria. Constructing artificial photosynthetic systems that structurally and functionally mimic these natural assemblies remains a critical challenge. Here, we report a spherical chromatophore nanomicelle system that mimics both LH2 and LH1-RC in water. This system is constructed through hierarchical coassembly of an amphiphilic porphyrin-based bacteriochlorophyll analogue and a cationic molecular nickel catalyst. Cryogenic electron microscopy directly resolves high-resolution ring-like structures on the nanomicelle surface, providing the first visual confirmation of the biomimetic architecture. The system achieves photocatalytic hydrogen evolution with a turnover number exceeding 667,000 over 72 h and a turnover frequency of above 9000 h-1 with an absolute hydrogen yield of 1.34 μmol─40 times greater than the nonassembled free molecular system─along with an initial external quantum efficiency of 6.8% at 435 nm. This outstanding performance originates from the well-defined spatial organization of the photosensitizers and catalysts, which facilitates efficient light harvesting and directional energy/electron transfer. Our work establishes a promising strategy for constructing high-performance artificial photosynthetic systems through rational biomimetic design.
- 7 January 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (2) , 1752-1765
Discovery of a Piperazine-Based Quaternary Ammonium Macrocycle as a Universal Reversal Agent for Heparin Anticoagulants
The development of a biocompatible antidote that can efficiently neutralize the anticoagulation activity of both unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs) represents an unmet medical need. Here, we report that a piperazine-derived tetracationic macrocycle can efficiently neutralize both UFH and LMWHs, including dalteparin, enoxaparin, and nadroparin. In vitro and in vivo assays reveal that the compound outperforms protamine, exhibiting significantly improved neutralization activity, a broad therapeutic window for all heparins, and high biocompatibility, which is confirmed by its very low coagulation and hemolysis effect, as well as a high therapeutic index (20.5), defined as the ratio of the maximum tolerated dose to the effective therapeutic dose. Molecular dynamics simulations indicate that binding may occur through interlocked threading and direct contact patterns, which are stabilized by intermolecular hydrogen bonding and ion-pair electrostatic attraction.
- 7 January 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (2) , 1752-1765
Discovery of a Piperazine-Based Quaternary Ammonium Macrocycle as a Universal Reversal Agent for Heparin Anticoagulants
The development of a biocompatible antidote that can efficiently neutralize the anticoagulation activity of both unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs) represents an unmet medical need. Here, we report that a piperazine-derived tetracationic macrocycle can efficiently neutralize both UFH and LMWHs, including dalteparin, enoxaparin, and nadroparin. In vitro and in vivo assays reveal that the compound outperforms protamine, exhibiting significantly improved neutralization activity, a broad therapeutic window for all heparins, and high biocompatibility, which is confirmed by its very low coagulation and hemolysis effect, as well as a high therapeutic index (20.5), defined as the ratio of the maximum tolerated dose to the effective therapeutic dose. Molecular dynamics simulations indicate that binding may occur through interlocked threading and direct contact patterns, which are stabilized by intermolecular hydrogen bonding and ion-pair electrostatic attraction.